6505--Order for Impavido (miltefosine), Puget Sound VA Medical Center

Award Notice Posted

Not the latest version. See the latest special notice from .

Solicitation number
36C26025P0684
Agency
Awarded
to Profounda Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
36C26025P0684 Federal contract award

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs Veterans Health Administration, through its Veterans Integrated Service Network 20, has awarded a sole-source contract (36C26025P0684) to Profounda Inc. for the procurement of Impavido (miltefosine), a specialized oral prescription treatment for Disseminated Cutaneous Acanthamboeba. The contract, valued at $299,700.00, will cover the period from May 1, 2025, to October 30, 2025, and will be fulfilled for the Puget Sound VA Medical Center. Market research confirmed that Profounda Inc. is the exclusive manufacturer and licenseholder of this drug in the United States, with no alternative treatment options available, which justified the sole-source procurement under the statutory authority of 41 USC 3304(a)(1). The contract was processed through the Network Contracting Office in Vancouver, Washington, with Profounda Inc. located in Orlando, Florida.

Notice text

Awarded contract 36C26025P0684 to PROFOUNDA INC for 299700.00 on 2025-05-01.

Files

File Type Posted
P03 36C260-25-AP-2676.pdf PDF
36C26025P0684_1.docx DOCX document

Notice history

Notice Type Posted
6505--Bulk Order Impavido (miltefosine) Latest special notice Special Notice
This notice Award Award Notice

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors